Positions

Assistant Professor

Department of Medicine
Division of Hematology and Oncology
Dan L Duncan Comprehensive Cancer Center - Baylor College of Medicine
Houston, Texas United States

Addresses

Dan L Duncan Comprehensive Cancer Center (Clinic)

O’Quinn Medical Tower at Baylor St. Luke’s Medical Center’s McNair Campus
Houston, TX 77054
United States
Phone: (832) 957-6500
Fax: (713) 610-4599

McNair Campus (Office)

7200 Cambridge Street, Suite A07.191
Houston, TX 77030
United States
Phone: (713) 798-1000
Fax: (713) 798-6677

Education

MD from Cairo University School of Medicine

12/2010 - Cairo, Egypt

MS from Cairo University School of Medicine

05/2015 - Cairo, Egypt

MPH from American Public University

04/2024 - West Virginia, United States

MBA from Georgia Southwestern State University

05/2024 - Americus, Georgia United States

Internship at Kasr Alainy Hospitals - Cairo University School of Medicine

02/2012 - Cairo, Egypt

Residency at Kasr Alainy Center of Clinical Oncology - Cairo University School of Medicine

10/2015 - Cairo, Egypt

Observership at Memorial Sloan-Kettering Cancer Center

06/2015 - New York, New York United States

Observership at The University of Texas MD Anderson Cancer Center

09/2015 - Houston, Texas United States

Observership at Baylor St. Luke's Medical Center - Baylor College of Medicine

10/2015 - Houston, Texas United States

Observership at The University of Alabama at Birmingham (UAB) Hospital

04/2016 - Birmingham, Alabama United States

Internship at The University of Texas MD Anderson Cancer Center

05/2017 - Houston, Texas United States

Clinical Fellowship at The University of Texas MD Anderson Cancer Center

06/2018 - Houston, Texas United States

Residency at Saint Barnabas Hospital, Albert Einstein College of Medicine

06/2021 - Bronx, New York United States

Clinical Fellowship at Mayo Clinic

06/2024 - Jacksonville, Florida United States

Certifications

American Board of Internal Medicine

American Board of Hematology

Honors & Awards

Fellow of American College of Physicians (FACP)

07/2024

FDA-AACR Oncology Educational Fellowship

10/2023 - 05/2024

Assistant Professor of Medicine, Division of Hematology and Oncology

Mayo Clinic (10/2023 - 06/2024)

Florida American Society of Clinical Oncology (FLASCO) Travel Grant Award

02/2022

ASH Annual Meeting Abstract Achievement Award

American Society of Hematology (ASH) (12/2021)

Conquer Cancer Foundation of ASCO 2018 Annual Meeting Merit Award

American Society of Clinical Oncology (ASCO) (06/2018)

AMAAC Young Oncologist Educational Grant

Arab Medical Association Against Cancer (AMAAC) (12/2016)

Selected Publications

• Ghorab, A., Al-Kali, A., Elliot, M., Gangat, N., Alkhateeb, H., Shah, M., ... & Badar, T. "Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs." Blood Cancer Journal. 2022 Jun 24;12(6):93. Pubmed PMID: 35750664
• Abouzid, M., Abdelhakeem, A., Elshafie, S., & Ghorab, A. "Heyde's syndrome: a challenging case of severe aortic stenosis and gastrointestinal bleeding." BMJ Case Reports. 2024 Apr;17(4):e258316. Pubmed PMID: 38631812
• Abou Dalle, I., Ghorab, A., Patel, K., Wang, X., Hwang, H., Cortes, J., ... & Borthakur, G. "Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemia." Blood Cancer Journal. 2020 May 4;10(5):48. Pubmed PMID: 32366841
• Jain, P., Kanagal‐Shamanna, R., Zhang, S., Ahmed, M., Ghorab, A., Zhang, L., ... & Wang, M. L. "Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib." British journal of haematology. 2018 Nov;183(4):578-587. Pubmed PMID: 30175400

Memberships

American Society of Hematology

American Society of Clinical Oncology

American Association for Cancer Research

American College of Physicians

Society of Hematologic Oncology

Languages

Arabic